Acarbose

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Acarbose and local guidelines before prescribing.

Alpha-glucosidase inhibitor (antidiabetic)

Mechanism

Alpha-glucosidase inhibitor that slows intestinal carbohydrate digestion and post-meal glucose rise.

Uses

Type 2 diabetes as an add-on.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Flatulence, abdominal bloating, diarrhoea; rarely raised liver enzymes.

Interactions

Hypoglycaemia from other agents must be treated with glucose, not sucrose.

Contraindications and cautions

Inflammatory bowel disease, intestinal obstruction, hernia; caution with severe renal impairment

Monitoring

HbA1c, LFT at high dose

Pregnancy and breastfeeding

Avoid; insulin preferred

Renal and hepatic impairment

Avoid if eGFR below 25

Overdose and reversal

Treat hypoglycaemia with glucose, not sucrose

Special advice

Take with the first mouthful of food; treat hypoglycaemia with glucose; avoid in inflammatory bowel disease or intestinal obstruction.

More from the textbook: uses, cautions and other points
Where it is discussed in the book